A North East company specialising in biological threat detection is adapting its air monitoring technology to detect COVID-19.
Kromek has received £1.25 million from Innovate UK to customise its pioneering system for automated detection of all airborne pathogens, including coronavirus.
Alongside the £1.25 million Innovate UK funding, Kromek has secured an additional £5 million from the Defense Advanced Research Project Agency (DARPA) – a long-term customer of the group.
Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets.